Williamson Legacy Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-11,760
Closed -$1.26M 105
2025
Q2
$1.26M Buy
11,760
+123
+1% +$12.4K 1.06% 40
2025
Q1
$1.17M Buy
11,637
+551
+5% +$55.5K 1.11% 38
2024
Q4
$990K Buy
11,086
+721
+7% +$63.5K 0.66% 45
2024
Q3
$869K Buy
+10,365
New +$817K 0.58% 58

Other funds holding BSX

Williamson Legacy Group's BSX Position: Q3 2025 in Review

Williamson Legacy Group sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 11,760 shares — an estimated $1.26M sold.

Williamson Legacy Group first reported a position in BSX in Q3 2024 and held it in 4 quarters. The position peaked at $1.26M in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Williamson Legacy Group reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Williamson Legacy Group sold 11,760 Boston Scientific shares in Q3 2025, an estimated $1.26M.
  • Williamson Legacy Group first reported a position in Boston Scientific in Q3 2024 and held it in 4 quarters.
  • Williamson Legacy Group's Boston Scientific position peaked at $1.26M in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Williamson Legacy Group's 13F filing for Q3 2025, filed 14 Nov 2025.